Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Taiwan Scientists Test Protein Enabling Colorectal, Cervical Cancers

This article was originally published in PharmAsia News

Executive Summary

Tawainese researchers are testing an adaptor protein that causes cancer as a likely target for treating colorectal, cervical and possibly other cancers. The scientific team said the Eps8 protein had been linked to colorectal cancer two years ago, and then to cervical cancer, but now the researchers believe it enhances the proliferation of cells associated with the two cancers. By lowering the level of Eps8 in animals, the team achieved a decrease in tumor growth. (Click here for more



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts